BinaxNOW COVID-19 is a lateral flow test, meaning that if a patient tests positive, the solutions Griffin creates will result in a sample line lighting up on a testing strip.
Griffin’s favorite part of her work at Abbott is feeling like she’s doing something to help the world in a time of unprecedented uncertainty. “Combined with the vaccine and sustained preventative measures, rapid testing is going to be a big part of ending this pandemic. What I do may only be a small part of the larger operation, but I have already seen it helping people in my community and hope that it will continue to do so,” she said.
This isn’t Griffin’s first time working to use science for good. While at IC, she interned every summer in an infectious disease lab, doing diagnostic testing and animal diagnostics. She also worked with Andrew Smith, professor of biology, in his lab doing research on the adhesive properties of slug mucus. The goal of their research is to learn how the bonding works in order to one day create a slug-inspired synthetic adhesive that could be used to replace staples and stitches in medical settings. She says these experiences helped her land her current role at Abbott Labs.